Qiagen readying updated respiratory panel for emergency 2019-nCoV testing
Qiagen is developing a pair of molecular assays to detect the 2019 novel coronavirus (2019-nCoV) from nasal…
thematics
#Microfluidics
Show filters
Markets
Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones
GenapSys launches sequencer in Asia amid deadly coronavirus outbreak and announces $75 million new funding
Expansion and engineering of allogeneic natural killer cells for enhanced anti-tumor activity
